Comparison of Isovue 370 vs. Standard Protocol in Coronary Computed Tomographic Angiography (CTA)
- Conditions
- Coronary Computed Tomographic Angiography
- Interventions
- Registration Number
- NCT02171247
- Lead Sponsor
- Duke University
- Brief Summary
Computed Tomography Angiogram (CTA) scans are performed routinely to look at the vessels in the body as an alternative to directly injecting contrast into the vessels and taking pictures. Different types of intravenous (into the vein, IV) contrast are available to fill the vessels and make them easier to see. The purpose of the study is to determine the best type of contrast for this scan.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 35
- adult patients who are referred for coronary CTA for suspected or known coronary artery disease
- creatinine greater than 2.0
- allergy to contrast media
- patients under the age of 18
- women who are pregnant or breast feeding
- patients with cardiac arrhythmia will also be excluded
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Isovue 370 Isovue 370 Isovue 370 is a contrast agent with increased iodine concentration. Visipaque 320 Visipaque 320 Standard protocol is Visipaque 320.
- Primary Outcome Measures
Name Time Method Contrast to Noise Ratio during scan, approximately 3 hours Contrast-to-noise ratios (CNRs) were calculated as follows: CNR = (vascular attenuation - myocardium attenuation) / SD of mean noise attenuation.
Image Quality during scan, approximately 3 hours Depiction of Branch Vessels - coronary branch depiction was performed as consensus decisions of two blinded radiologists. Criteria used was abscence or presence of vessels.
Motion Artifact during scan, approximately 3 hours The outcome will be measured by individual scores. The scores from multiple readers will be averaged.
Attenuation of the Ascending Aorta and Coronary Arteries during scan, approximately 3 hours The investigator will measure the length of visualized coronary artery for the left anterior descending, left circumflex and right coronary arteries as a way of quantifying visualization of distal coronary segments.
- Secondary Outcome Measures
Name Time Method